Delivra Health Brands Inc. (TSXV: DHB)
DHB trades on the TSX Venture Exchange in Life Sciences, headquartered in British Columbia. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of October 31, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for DHB.V, last bar 2026-11-13, computed by MarginsX.
Profile
| Field | Value |
|---|---|
| Ticker | DHB on the TSX Venture Exchange |
| Yahoo symbol | DHB.V |
| Sector | Life Sciences, Cannabis |
| Headquarters | British Columbia |
| Listed | 2017-04-28 |
| Listing type | QT from NEX |
| Shares outstanding | 31,261,781 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | No SEC filer matched on exact name with a Canadian address or US interlisting |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | 0.0% |
| 1 week | +12.5% |
| 1 month | +5.9% |
| 3 months | -10.0% |
| 6 months | -30.8% |
| Year to date | -56.1% |
| 1 year | -70.5% |
| From 52-week high | -70.0% |
| 52-week range | C$0.0750 to C$0.3000 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
110 documents in 6 types. Each title links to the document at its source.
Annual financial statements (7)
| Document | Type | Filed |
|---|---|---|
| Year End 2018 Financials Statements 876kb Period Year ended June 30, 2018 | Annual financial statements | 2026-02-28 |
| Financial Statements - for the year ending June 30, 2023 600kb Period 2023-09-30 | Annual financial statements | 2023-06-30 |
| Year End 2022 Financial Statements 4.8mb Period 2022-09-30 | Annual financial statements | 2022-09-30 |
| Year End 2021 Financial Statements 628kb Period 2021-09-30 | Annual financial statements | 2021-09-30 |
Interim financial statements (27)
| Document | Type | Filed |
|---|---|---|
| Financial Statements - For the three and nine months ended March 31, 2026 623kb Period Q3 2026 | Interim financial statements | 2026-03-31 |
| Financial Statements - For the three and six months ended December 31, 2025 622kb Period 2025-12-31 | Interim financial statements | 2025-12-31 |
| Financial Statements - For the three months ended September 30th, 2025 570kb Period 2025-12-31 | Interim financial statements | 2025-09-30 |
| Financial Statements - For the three and nine months ended March 31, 2025 661kb Period Q3 2025 | Interim financial statements | 2025-03-31 |
MD&A (37)
| Document | Type | Filed |
|---|---|---|
| Year End 2021 Management Discussion & Analysis 1.5mb | MD&A (annual) | 2026-02-28 |
| Year End 2022 Management Discussion & Analysis 1.5mb | MD&A (annual) | 2026-02-28 |
| Year End 2020 Management Discussion & Analysis 1037kb | MD&A (annual) | 2026-02-28 |
| Year End 2018 Management Discussion & Analysis 713kb | MD&A (annual) | 2026-02-28 |
News release (3)
| Document | Type | Filed |
|---|---|---|
| Nov 13, 2026 Delivra Health Issues News Release Amendment Regarding Proposed Shares for Debt Transaction Read More | News release | 2026-11-13 |
| Nov 11, 2026 Delivra Health Announces Proposed Shares for Debt Transaction Read More Period FY2026 | News release | 2026-11-11 |
| Oct 28, 2026 Delivra Health Brands Reports FY2026 Financial Results Read More Period FY2026 | News release | 2026-10-28 |
Management information circular / proxy (25)
| Document | Type | Filed |
|---|---|---|
| 2020 Notice of Meeting and Information Circular 1.7mb Period FY2020 | Management information circular | No date |
| 2022 AGM Circular 1871kb | Management information circular | No date |
| 2021 AGM Circular 288kb | Management information circular | No date |
| 2023 AGM Circular 416kb | Management information circular | No date |
Other (11)
| Document | Type | Filed |
|---|---|---|
| Factsheet | Investor presentation | No date |
| Investor Presentation | Investor presentation | No date |
| Financial Statements - For the year ending June 30, 2026 1.5mb | Financial statements (period not stated) | 2026-06-30 |
| Financial Statements - For the year ending June 30th, 2025 670kb | Financial statements (period not stated) | 2025-06-30 |
Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| ZCT | Zero Candida Technologies Inc. | TSXV | C$2.2M | -4.5% | -56.3% |
| THRM | Therma Bright Inc. | TSXV | C$2.0M | -28.6% | -68.8% |
| EKG | CardioComm Solutions Inc. | TSXV | C$2.0M | 0.0% | 0.0% |
| AJA | Aja Health and Wellness Inc. | TSXV | C$3.0M | 0.0% | 0.0% |
| QPT | Quest Pharmatech Inc. | TSXV | C$3.4M | 0.0% | -50.0% |
The app has the price chart, every filing, private raises and the full peer set for DHB.
Open in the app